In our previous report, we showed that Milmed yeast addition to human SK-N-SH neuroblastoma cells promoted the expression of BDNF and NGF, confirming that Milmed co-treatment may be suitable for several neurologic and neuropsychiatric disorders [2]. The gene discussed is NGF; the disease is neuroblastoma.